Targeted apc;twist double-mutant mice: a new model of spontaneous osteosarcoma that mimics the human disease

Natacha Entz-Werlé1, Philippe Choquet, Agnès Neuville

  • 1Pédiatrie Onco-Hématologie, CHRU Hautepierre, Strasbourg, France.

Translational Oncology
|December 15, 2010
PubMed

Insights

The loss of TWIST and adenomatosis polyposis coli (APC) genes contributes to osteosarcoma development. A new mouse model with combined gene loss frequently develops localized bone tumors resembling human osteosarcomas.

Area of Science:

  • Oncology
  • Developmental Biology
  • Genetics

Background:

  • TWIST and adenomatosis polyposis coli (APC) are crucial for bone development.
  • Concurrent loss of TWIST and APC genes is frequently observed in pediatric osteosarcoma patients.

Purpose of the Study:

  • To investigate the oncogenic cooperation between TWIST and APC genes.
  • To develop and characterize a novel animal model for osteosarcoma research.

Main Methods:

  • Intercrosses between twist-null/+ and Apc1638N/+ mice.
  • Macroscopic skeletal analyses, in vivo imaging, histology, and cellular/molecular analyses.
  • Immunofluorescence for bone differentiation markers (e.g., Runx2, pRb).

Main Results:

  • Apc1638N/+;twist-null/+ mice developed spontaneous, localized malignant bone tumors.
  • Murine tumors exhibited fibroblastic, chondroblastic, and osteoblastic osteosarcoma histologies, mimicking human subtypes.
  • Tumor cells showed altered expression of bone differentiation markers, including undetectable Runx2 and abundant phosphorylated retinoblastoma.

Conclusions:

  • The developed mouse model recapitulates key features of human localized osteosarcomas.
  • This model serves as a valuable tool for understanding osteosarcoma development and progression.
  • The findings highlight the critical role of TWIST and APC in bone tumor suppression.